<DOC>
	<DOCNO>NCT00686725</DOCNO>
	<brief_summary>The primary purpose study evaluate efficacy safety early postsurgery temozolomide chemotherapy follow standard temozolomide regimen , compare standard regimen alone , treatment patient newly diagnose glioblastoma multiforme .</brief_summary>
	<brief_title>Standard Temodal ( Temozolomide ) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal Newly Diagnosed Glioblastoma Multiforme ( Study P05572 )</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>Dacarbazine</mesh_term>
	<criteria>Only patient meet criterion enrol study : Patients prior histological confirmation newly diagnose primary glioblastoma multiforme supratentorial cerebral hemisphere . Gross total resection partial resection ( image ) &gt; 70 % . At least capable obtain tissue sample MGMT analysis surgery . Chemoradiotherapy expect Week 5 ( Day 29 ) surgery . Age &gt; =18 &lt; =70 year . Eastern Cooperative Oncology Group ( ECOG ) performance status 0 , 1 , 2 . Life expectancy &gt; =9 month . Laboratory test value must satisfy follow criterion : absolute neutrophil count &gt; =1.5 x 10^9/L ; platelet count &gt; =100 x 10^9/L ; hemoglobin &gt; =80 g/L ; blood urea nitrogen creatinine &lt; 1.5 x upper limit normal value ( ULN ) ; total bilirubin direct bilirubin &lt; 1.5 x ULN ; alanine aminotransferase aspartate aminotransferase &lt; 3 x ULN ; alkaline phosphatase &lt; 2 x ULN . Patients must willing provide write informed consent . Patients childbearing potential ( include female subject female partner male subject ) must use effective method contraception . Patients enrol follow criterion apply : Patient previous current malignancy ( except melanoma ) sit , unless disease free least 3 year . Patient receive chemotherapy , radiotherapy study indication , medication antitumor indication prior surgery . Patient recurrent multiple malignant glioma ( include gliomatosis cerebri ) . Patient metastatic lesion subtentorial outside calvaria . Patient receive chemotherapy radiotherapy sensitizer head neck tumor . Patient receive radiotherapy head neck lead radiotherapy domain overlap . Patient acute infection require intravenous antibiotic . Frequent vomit medical condition could interfere oral medication intake ( eg , partial bowel obstruction ) . Known human immunodeficiency virus ( HIV ) positive acquire immune deficiency syndrome ( AIDS ) relate illness . Woman pregnant breastfeeding . Patient history hypersensitivity temozolomide analogic alkylating agent . Patient condition investigator think subject suitable enrolment , like know subject may good compliance .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>